SynBiotic SE (FRA:SBX)

SynBiotic SE Statistics

Total Valuation

SynBiotic SE has a market cap or net worth of EUR 19.95 million. The enterprise value is 21.57 million.

Market Cap	19.95M
Enterprise Value	21.57M

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	6.82M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.17
PB Ratio	1.30
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.03
EV / Sales	5.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.33

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.27.

Current Ratio	0.81
Quick Ratio	0.33
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	-1.41
Interest Coverage	-43.09

Financial Efficiency

Return on equity (ROE) is -61.58% and return on invested capital (ROIC) is -22.02%.

Return on Equity (ROE)	-61.58%
Return on Assets (ROA)	-13.92%
Return on Invested Capital (ROIC)	-22.02%
Return on Capital Employed (ROCE)	-31.27%
Revenue Per Employee	70,206
Profits Per Employee	-193,284
Employee Count	55
Asset Turnover	0.10
Inventory Turnover	0.76

Taxes

Income Tax	-134,909
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-54.47%
50-Day Moving Average	2.89
200-Day Moving Average	3.25
Relative Strength Index (RSI)	35.09
Average Volume (20 Days)	827

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SynBiotic SE had revenue of EUR 3.86 million and -10.63 million in losses. Loss per share was -2.24.

Revenue	3.86M
Gross Profit	1.51M
Operating Income	-8.41M
Pretax Income	-11.87M
Net Income	-10.63M
EBITDA	-7.54M
EBIT	-8.41M
Loss Per Share	-2.24

Balance Sheet

The company has 2.07 million in cash and 4.15 million in debt, giving a net cash position of -2.08 million.

Cash & Cash Equivalents	2.07M
Total Debt	4.15M
Net Cash	-2.08M
Net Cash Per Share	n/a
Equity (Book Value)	15.33M
Book Value Per Share	3.15
Working Capital	-1.49M

Cash Flow

In the last 12 months, operating cash flow was -2.92 million and capital expenditures -19,181, giving a free cash flow of -2.94 million.

Operating Cash Flow	-2.92M
Capital Expenditures	-19,181
Free Cash Flow	-2.94M
FCF Per Share	n/a

Margins

Gross margin is 39.01%, with operating and profit margins of -217.87% and -275.31%.

Gross Margin	39.01%
Operating Margin	-217.87%
Pretax Margin	-307.44%
Profit Margin	-275.31%
EBITDA Margin	-195.39%
EBIT Margin	-217.87%
FCF Margin	n/a

Dividends & Yields

SynBiotic SE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,799.73%
Shareholder Yield	-1,799.73%
Earnings Yield	-53.29%
FCF Yield	-14.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SynBiotic SE has an Altman Z-Score of -1.86 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.86
Piotroski F-Score	1